Managers / Q3 2020 · view latest →
One68 Global Capital, LLC
CIK 0001755535 · 135 WEST 50TH STREET, SUITE 200, NEW YORK, NY, 10020 · 212-331-6783
Summary
One68 Global Capital, LLC reported $38M in U.S.-listed holdings across 39 positions for Q3 2020.
The portfolio is heavily concentrated: ACIA alone accounts for 21.3% of reported value.
Compared with Q2 2020, the fund opened 32 new positions and exited 15.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 72.5% · $27M
- Other · 17.3% · $7M
- Right · 8.2% · $3M
- ETP · 2.0% · $749,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IMMUIMMUNOMEDICS INC | NEW | +61.0K | 61.0K | +$5M | $5M |
| CLGXCORELOGIC INC | NEW | +36.5K | 36.5K | +$2M | $2M |
| LIONHEART ACQUISITION CORP I | NEW | +150.0K | 150.0K | +$1M | $1M |
| VIRTUSA CORP | NEW | +30.3K | 30.3K | +$1M | $1M |
| BHCBAUSCH HEALTH COS INC | NEW | +93.8K | 93.8K | +$1M | $1M |
| PROSHARES TR II | NEW | +63.0K | 63.0K | +$1M | $1M |
| DANDANA INCORPORATED | NEW | +81.8K | 81.8K | +$1M | $1M |
| GNWGENWORTH FINL INC | NEW | +300.2K | 300.2K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ACIAACACIA COMMUNICATIONS INChistory → | Common Stock | 21.32% | $8M | 119.2K |
| 2 | IMMUIMMUNOMEDICS INChistory → | Common Stock | 13.76% | $5M | 61.0K |
| 3 | BRISTOL-MYERS SQUIBB CO | RIGHT · Right | 8.17% | $3M | 122.5K |
| 4 | CLGXCORELOGIC INChistory → | Common Stock | 6.56% | $2M | 36.5K |
| 5 | LIONHEART ACQUISITION CORP I | Unit | 3.96% | $1M | 150.0K |
| 6 | VIRTUSA CORP | Common Stock | 3.95% | $1M | 30.3K |
| 7 | BHCBAUSCH HEALTH COS INChistory → | Common Stock | 3.87% | $1M | 93.8K |
| 8 | PROSHARES TR II | ETP | 3.33% | $1M | 63.0K |
| 9 | GRWGGROWGENERATION CORPhistory → | Common Stock | 3.29% | $1M | 77.6K |
| 10 | DANDANA INCORPORATEDhistory → | Common Stock | 2.67% | $1M | 81.8K |
| 11 | GNWGENWORTH FINL INChistory → | Common Stock | 2.67% | $1M | 300.2K |
| 12 | GX ACQUISITION CORP | Common Stock | 2.24% | $846,000 | 80.5K |
| 13 | VROOM INC | Common Stock | 2.20% | $828,000 | 16.0K |
| 14 | XLESELECT SECTOR SPDR TRhistory → | ETP | 1.99% | $749,000 | 25.0K |
| 15 | K12 INC | Common Stock | 1.84% | $694,000 | 26.3K |
| 16 | GILDGILEAD SCIENCES INChistory → | Common Stock | 1.68% | $632,000 | 10.0K |
| 17 | PFEPFIZER INChistory → | Common Stock | 1.46% | $551,000 | 15.0K |
| 18 | FINSERV ACQUISITION CORP | Common Stock | 1.39% | $522,000 | 52.1K |
| 19 | LIVEXLIVE MEDIA INC | Common Stock | 1.33% | $500,000 | 192.7K |
| 20 | LVSLAS VEGAS SANDS CORPhistory → | Common Stock | 1.24% | $467,000 | 10.0K |
| 21 | CLDRCLOUDERA INChistory → | Common Stock | 1.21% | $456,000 | 41.8K |
| 22 | GIGCAPITAL2 INC | Common Stock | 0.96% | $362,000 | 35.6K |
| 23 | NSLRSURO CAPITAL CORP | Common Stock | 0.86% | $325,000 | 30.0K |
| 24 | TAT&T INC | Common Stock | 0.76% | $285,000 | 10.0K |
| 25 | GORES METROPOULOS INC | Common Stock | 0.75% | $283,000 | 24.8K |
| 26 | CNXCNX RES CORP | Common Stock | 0.75% | $283,000 | 30.0K |
| 27 | ACAMAR PARTNERS ACQUISITI- A | Common Stock | 0.72% | $271,000 | 26.5K |
| 28 | FINTECH ACQUISITION CORP III | Common Stock | 0.68% | $257,000 | 24.9K |
| 29 | UBERUBER TECHNOLOGIES INC | Common Stock | 0.68% | $255,000 | 7.0K |
| 30 | NEW PROVIDENCE ACQUISITION | Common Stock | 0.67% | $252,000 | 25.0K |
| 31 | HAYMAKER ACQUISITION CORP II | Common Stock | 0.66% | $247,000 | 24.7K |
| 32 | ARTIUS ACQUISITION INC | Unit | 0.55% | $208,000 | 20.0K |
| 33 | CF FINANCE ACQUISITION CORP | Unit | 0.53% | $200,000 | 20.0K |
| 34 | NEUROTROPE INC | Common Stock | 0.42% | $160,000 | 144.6K |
| 35 | E MERGE TECHNOLOGY ACQUISITI | Unit | 0.27% | $101,000 | 10.0K |
| 36 | CRESCENT ACQUISITION CORP | Common Stock | 0.27% | $100,000 | 10.0K |
| 37 | SILVERCREST METALS INC | Common Stock | 0.23% | $85,000 | 10.0K |
| 38 | HYREQHYRECAR INC | Common Stock | 0.12% | $45,000 | 14.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $31M | 40 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $8M | 35 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $6M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $0 | 1 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $204M | 90 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $188M | 98 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $16M | 28 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $70M | 57 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $36M | 25 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $38M | 39 | May 18, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $50M | 119 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $38M | 39 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $27M | 21 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $10M | 10 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $46M | 78 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $44M | 14 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $79M | 18 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $33M | 18 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $22M | 12 | Feb 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.